| Popis: |
A 26-year-old man with a 3-year history of type 2 diabetes was admitted to the hospital with respiratory illness and abdominal symptoms attributed to coronavirus disease 2019 (COVID-19) infection. He had a history of intermittent insulin use and three or four hospital admissions for diabetic ketoacidosis (DKA) within the first 2 years of diagnosis. In the 3 months before this admission, he again discontinued insulin therapy but continued the sodium–glucose cotransporter 2 (SGLT2) inhibitor canagliflozin and glipizide that was prescribed by his primary care provider. |
